Earnings Feed
Start Free
Home/Filings/4/0001144204-15-069759
4//SEC Filing

PHARMATHENE, INC 4

Accession 0001144204-15-069759

$ALTCIK 0001326190operating
View on SEC.govCompany Profile

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 8:16 PM ET

Size

7.5 KB

Accession

0001144204-15-069759

Insider Transaction Report

Form 4
Period: 2015-12-03
PHARMATHENE, INCPIP
MACNEILL PHILIP
Controller and PAO
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2015-12-03+25,000→ 50,000 total
  • Award

    Stock Options (right to buy)

    2015-12-03+70,625→ 70,625 total
    Exercise: $1.66Exp: 2025-12-03→ Common Stock (70,625 underlying)
Footnotes (3)
  • [F1]Represents a grant of shares of restricted stock with 50% of the shares vesting on December 3, 2016 and the remaining 50% vesting on December 3, 2017. These vesting dates may be accelerated pursuant to the terms of the relevant Restricted Stock Agreement if certain circumstances occur.
  • [F2]On December 3, 2015, the date of grant, the closing price of the Issuer's common stock on the NYSE MKT was $1.66 per share.
  • [F3]The options vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date.

Documents

1 file

Issuer

PHARMATHENE, INC

CIK 0001326190

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001326190

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:16 PM ET
Size
7.5 KB
View on SEC.gov